111 PE Ratio 2018-2023 | YI
Current and historical p/e ratio for 111 (YI) from 2018 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. 111 PE ratio as of May 20, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| 111 PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-20 | 1.33 | 0.00 | |
| 2023-12-31 | 1.55 | $-0.32 | 0.00 |
| 2023-09-30 | 2.60 | $-0.52 | 0.00 |
| 2023-06-30 | 2.46 | $-0.52 | 0.00 |
| 2023-03-31 | 2.65 | $-0.60 | 0.00 |
| 2022-12-31 | 3.02 | $-0.74 | 0.00 |
| 2022-09-30 | 2.68 | $-0.76 | 0.00 |
| 2022-06-30 | 2.06 | $-1.08 | 0.00 |
| 2022-03-31 | 2.66 | $-1.20 | 0.00 |
| 2021-12-31 | 3.50 | $-1.28 | 0.00 |
| 2021-09-30 | 6.17 | $-1.30 | 0.00 |
| 2021-06-30 | 9.09 | $-1.02 | 0.00 |
| 2021-03-31 | 13.80 | $-0.94 | 0.00 |
| 2020-12-31 | 6.95 | $-1.06 | 0.00 |
| 2020-09-30 | 6.20 | $-0.98 | 0.00 |
| 2019-03-31 | 6.49 | $-1.00 | 0.00 |
| 2018-09-30 | 13.52 | $-1.06 | 0.00 |
| 2020-06-30 | 6.35 | $-0.88 | 0.00 |
| 2020-03-31 | 6.61 | $-0.90 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.111B | $2.105B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.366B | 20.52 |
| Inspire Medical Systems (INSP) | United States | $4.612B | 0.00 |
| Axonics (AXNX) | United States | $3.446B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.129B | 0.00 |
| 10x Genomics (TXG) | United States | $2.980B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.978B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.950B | 0.00 |
| Enovis (ENOV) | United States | $2.875B | 21.31 |
| Azenta (AZTA) | United States | $2.743B | 154.15 |
| Privia Health (PRVA) | United States | $2.016B | 112.67 |
| Schrodinger (SDGR) | United States | $1.654B | 0.00 |
| Omnicell (OMCL) | United States | $1.398B | 48.32 |
| Phreesia (PHR) | United States | $1.393B | 0.00 |
| Standard BioTools (LAB) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.662B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.649B | 0.00 |
| Talkspace (TALK) | United States | $0.467B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.442B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.410B | 0.00 |
| Pulmonx (LUNG) | United States | $0.349B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.191B | 0.00 |
| Outset Medical (OM) | United States | $0.187B | 0.00 |
| American Well (AMWL) | United States | $0.145B | 0.00 |
| TruBridge (TBRG) | United States | $0.134B | 7.19 |
| MSP Recovery (LIFW) | United States | $0.107B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.064B | 0.00 |
| Augmedix (AUGX) | United States | $0.059B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.042B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.010B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |